Hdac inhibitors for use with nk cell based therapies
US-2026007676-A1 · Jan 8, 2026 · US
Viracta Therapeutics Inc holds 13 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 13 |
| Recent patents | 6 |
| First publication | Mar 28, 2019 |
| Latest publication | Jan 8, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026007676-A1 · Jan 8, 2026 · US
US-12427152-B2 · Sep 30, 2025 · US
US-2024417389-A1 · Dec 19, 2024 · US
US-2024342172-A1 · Oct 17, 2024 · US
US-2024294524-A1 · Sep 5, 2024 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026007676-A1 · Jan 8, 2026 · US
US-12427152-B2 · Sep 30, 2025 · US
US-2024417389-A1 · Dec 19, 2024 · US
US-2024342172-A1 · Oct 17, 2024 · US
US-2024294524-A1 · Sep 5, 2024 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 13 |
| Chemistry & Metallurgy | 9 |
| Cross-Sectional Technologies | 4 |
Answers are generated from the same data shown on this page.